Clinical trial
Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue…
NCT00424814 · ANRS, Emerging Infectious Diseases, Other · Completed
Key facts
| NCT number | NCT00424814 |
|---|---|
| Title | Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva |
| Official title | Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. A Multicenter Randomised Phase II/III Open Label Study With a Group of 100 Pregnant Women Receiving Lopinavir/Ritonavir and a Group of 50 Receiving… |
| Lead sponsor | ANRS, Emerging Infectious Diseases, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Kaletra (lopinavir/ritonavir), Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine) |
| Enrollment | 105 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2011 |
| Completion | Nov 1, 2012 |
| First posted | Jan 22, 2007 |
| Last update posted | Jul 18, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: